Asclepius Labs
Biotechnology - St. Louis, Missouri, United States
Asclepius Labs Employees
Asclepius Labs Details
In 2007 scientists at Asclepius Laboratories Inc. (Asclepius) discovered the Early Lineage Adult (ELA(r)) cell, an entirely new form of stem cell, a discovery heralded in 2014 as a breakthrough in the field of regenerative medicine. The Company is the only firm globally to own a composition of matter patent on a validated stem cell line and holds the exclusive worldwide license to the entire ELA(r) cell population. ELA(r) cells are the earliest and therefore the most plastic form of adult stem cells and have demonstrated efficacy significantly superior to that of the only other two patented stem cells in the market. The ELA(r) cell is genetically and phenotypically distinct from other adult stem cells, with the ability to differentiate into all three germ layers (mesoderm, endoderm and ectoderm), and therefore has the capacity to create either an identical copy of itself during culture or be induced to transform into many human cell types. By virtue of the company's patent on the entire population of the ELA(r) cells, Asclepius is able to identify and thereby own multiple generations of adult stem cell therapies.
